Sales rose 7% in Q2 with broad-based growth, record normalized gross margin, and improved EBITDA. New product launches and experiential activations drove momentum, while tariff credits and debt reduction strengthened the balance sheet.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.